Literature DB >> 26800994

The Biological Treatment of Paraphilic Disorders: an Updated Review.

Brian J Holoyda1, Denise C Kellaher2.   

Abstract

Paraphilic disorders are characterized by atypical sexual interests, fantasies, and behaviors that are subjectively distressing to patients or pose a risk of harm to others. By their very nature, some paraphilic disorders may predispose an individual to commit sexual offenses. The biological treatment of paraphilic disorders, then, is of paramount importance for psychiatry and society at large. Three categories of pharmacologic agents commonly used to treat paraphilic disorders are selective serotonin reuptake inhibitors, synthetic steroidal analogs, and gonadotropin-releasing hormone analogs. Each medication uses a different mechanism of action and has different effects on the physiological and psychological features of paraphilic disorders. In general, these medications have limited high-quality research to support their use. Despite this, some authors have proposed treatment algorithms for individuals with paraphilic disorders of varying severity. These guidelines offer clinicians potentially useful, rational approaches to assessing treatment need in individuals with paraphilic disorders. Recent neuroimaging research suggests that functional magnetic resonance imaging may offer further promise in effectively assessing paraphilic disorders to help direct treatment options.

Entities:  

Keywords:  Antiandrogen; Gonadotropin-releasing hormone analogs; Paraphilic disorder; Selective serotonin reuptake inhibitors; Sexual deviancy; Sexual offending

Mesh:

Substances:

Year:  2016        PMID: 26800994     DOI: 10.1007/s11920-015-0649-y

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  34 in total

1.  The neurobiology of sexual function.

Authors:  C M Meston; P F Frohlich
Journal:  Arch Gen Psychiatry       Date:  2000-11

Review 2.  Clinical effectiveness and cost-consequences of selective serotonin reuptake inhibitors in the treatment of sex offenders.

Authors:  Y Adi; D Ashcroft; K Browne; A Beech; A Fry-Smith; C Hyde
Journal:  Health Technol Assess       Date:  2002       Impact factor: 4.014

Review 3.  Sexual side effects of serotonergic antidepressants: mediated by inhibition of serotonin on central dopamine release?

Authors:  Elisabeth Y Bijlsma; Johnny S W Chan; Berend Olivier; Jan G Veening; Mark J Millan; Marcel D Waldinger; Ronald S Oosting
Journal:  Pharmacol Biochem Behav       Date:  2013-10-12       Impact factor: 3.533

Review 4.  Psychological interventions for adults who have sexually offended or are at risk of offending.

Authors:  Jane A Dennis; Omer Khan; Michael Ferriter; Nick Huband; Melanie J Powney; Conor Duggan
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

5.  Sexual offenders, violence and testosterone: a clinical study.

Authors:  J M Bradford; D McLean
Journal:  Can J Psychiatry       Date:  1984-06       Impact factor: 4.356

6.  The Oregon depo-Provera program: a five-year follow-up.

Authors:  Barry M Maletzky; Arthur Tolan; Bentson McFarland
Journal:  Sex Abuse       Date:  2006-07

Review 7.  Current concepts in the pharmacotherapy of paraphilias.

Authors:  Frederico D Garcia; Florence Thibaut
Journal:  Drugs       Date:  2011-04-16       Impact factor: 9.546

8.  Brain processing of visual sexual stimuli in healthy men: a functional magnetic resonance imaging study.

Authors:  Harold Mouras; Serge Stoléru; Jacques Bittoun; Dominique Glutron; Mélanie Pélégrini-Issac; Anne-Lise Paradis; Yves Burnod
Journal:  Neuroimage       Date:  2003-10       Impact factor: 6.556

9.  Sex hormones, neurotransmitters, and psychopharmacological treatments in men with paraphilic disorders.

Authors:  Fabian M Saleh; Fred S Berlin
Journal:  J Child Sex Abus       Date:  2003

Review 10.  Drug treatment of paraphilic and nonparaphilic sexual disorders.

Authors:  David R P Guay
Journal:  Clin Ther       Date:  2009-01       Impact factor: 3.393

View more
  1 in total

1.  Modeling Human Sexual Motivation in Rodents: Some Caveats.

Authors:  Olivia Le Moëne; Anders Ågmo
Journal:  Front Behav Neurosci       Date:  2019-08-27       Impact factor: 3.558

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.